Nocturia is an extremely common condition that has major sequelae for affected patients.
Through disruption of sleep, nocturia impairs quality of life and worsens health outcomes …

What's known on the subject? and What does the study add? A consensus statement
published in 2011 summarised current research, clinical approaches, and treatment options …

Objective To evaluate the effect of botulinum neurotoxin type‐A (BoNT‐A) on chronic
prostatitis/chronic pelvic pain syndrome (CP/CPPS) refractory to medical therapy. Materials …

Intravesical botulinum toxin (BoNT) injection is effective in reducing urgency and urinary
incontinence. It temporarily inhibits the detrusor muscle contraction by blocking the release …

Objective To evaluate published evidence on nocturia in men and derive expert
recommendations. Methods The International Consultations on Urological Diseases …

The use of onabotulinumtoxinA (BoNT-A) for the treatment of lower urinary tract diseases
(LUTD) has increased markedly in recent years. The indications for BoNT-A treatment of …

Abstract Treatment modalities for male lower urinary tract symptoms (LUTS) comprise a
broad spectrum of medical and surgical options. Interest is growing in minimally invasive …

Bladder dysfunction, which involves inadequacies of urine storage or emptying, increases
with age. Conventional medications may have insufficient efficacy for patients with refractory …

Urolift appears to be a well tolerated and effective minimally invasive treatment for lower
urinary tract symptoms due to BPH in men who wish to preserve sexual function or who are …

Botulinum toxin A (Botox) had been considered a promising drug that has an effect on
functional disorders of the lower urinary tract. Because Botox exhibits anti-inflammatory and …